Details for Patent: 8,735,380

✉ Email this page to a colleague

Which drugs does patent 8,735,380 protect, and when does it expire?

Patent 8,735,380 protects ELLA and is included in one NDA.

This patent has thirty-five patent family members in twenty-seven countries.

Summary for Patent: 8,735,380

Patent landscape, scope, and claims:

Title:	Ulipristal acetate tablets
Abstract:	The invention relates to a pharmaceutical tablet for oral administration comprising ulipristal acetate together with the following excipients: at least one diluent in an amount of 50 to 98.5 wt %, at least one binding agent in an amount of 0 to 10 wt %, at least one disintegrating agent in an amount of 0.5 to 10 wt %, and at least one lubricant in an amount of 0 to 10 wt %.
Inventor(s):	Gainer; Erin (Paris, FR), Guillard; Helene (Paris, FR), Gicquel; Denis (Orgeval, FR), Henrion; Marianne (Paris, FR), Gnakamene; Celine (Paris, FR)
Assignee:	Laboratoire HRA Pharma (Paris, FR)
Application Number:	13/140,219
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,735,380
Patent Claim Types: see list of patent claims	Formulation; Compound; Dosage form; Device;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,735,380

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lab Hra Pharma	ELLA	ulipristal acetate	TABLET;ORAL	022474-001	Aug 13, 2010	AB	RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,735,380

PCT Information
PCT Filed	December 08, 2009	PCT Application Number:	PCT/EP2009/066652
PCT Publication Date:	June 17, 2010	PCT Publication Number:	WO2010/066749

International Family Members for US Patent 8,735,380

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009326084	⤷ Subscribe
Brazil	PI0922796	⤷ Subscribe
Canada	2745084	⤷ Subscribe
China	102245173	⤷ Subscribe
China	105267168	⤷ Subscribe
Colombia	6400186	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.